Cytek Biosciences (CTKB) Gross Profit (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Cytek Biosciences | 566.95 Mn | 501.25 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.37% |
| Dec 31, 2025 | 19.36% |
| Sep 30, 2025 | 15.44% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -40.10% |
| Dec 31, 2024 | 16.02% |
| Sep 30, 2024 | 14.03% |
| Jun 30, 2024 | 10.53% |
| Mar 31, 2024 | -30.36% |
| Dec 31, 2023 | 21.60% |
| Sep 30, 2023 | -3.49% |
| Jun 30, 2023 | 33.86% |
| Mar 31, 2023 | -28.38% |
| Dec 31, 2022 | 9.35% |
| Sep 30, 2022 | 9.37% |
| Jun 30, 2022 | 21.73% |
| Mar 31, 2022 | -14.63% |
| Dec 31, 2021 | 11.09% |
| Sep 30, 2021 | 7.76% |
| Jun 30, 2021 | 36.30% |